Basit öğe kaydını göster

A subgroup analysis of the TROPIC trial exploring reason for discontinuation of prior docetaxel and survival outcome of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC).

dc.contributor.authorHansen, S.
dc.contributor.authorSartor, A. O.
dc.contributor.authorOzguroglu, M.
dc.contributor.authorMachiels, J. H.
dc.contributor.authorShen, L.
dc.contributor.authorDe Bono, J. S.
dc.contributor.authorOudard, S.
dc.date.accessioned2021-03-04T14:24:15Z
dc.date.available2021-03-04T14:24:15Z
dc.date.issued2011
dc.identifier.citationDe Bono J. S. , Oudard S., Ozguroglu M., Hansen S., Machiels J. H. , Shen L., Sartor A. O. , "A subgroup analysis of the TROPIC trial exploring reason for discontinuation of prior docetaxel and survival outcome of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC).", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.15, 2011
dc.identifier.issn0732-183X
dc.identifier.othervv_1032021
dc.identifier.otherav_81576c1f-b403-44cb-b109-ee97a00c936f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/88162
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.4526
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleA subgroup analysis of the TROPIC trial exploring reason for discontinuation of prior docetaxel and survival outcome of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC).
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume29
dc.identifier.issue15
dc.contributor.firstauthorID200442


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster